Araştırma Makalesi

Assessment of Xerostomia Levels in Patients Undergoing Hemodialysis Treatment/Hemodiyaliz Tedavisi Gören Hastalarda Kserostomi Düzeyinin Değerlendirilmesi

Cilt: 21 Sayı: 3 30 Eylül 2026
PDF İndir
TR EN

Assessment of Xerostomia Levels in Patients Undergoing Hemodialysis Treatment/Hemodiyaliz Tedavisi Gören Hastalarda Kserostomi Düzeyinin Değerlendirilmesi

Öz

Aim: The aim of this study was to evaluate xerostomia in patients undergoing haemodialysis from a nephrology nursing perspective and to examine the association between subjective xerostomia symptoms and objective indicators of oral dryness.
Materials and Methods: This descriptive, cross-sectional study included 40 patients undergoing haemodialysis at the Haemodialysis Unit of Sabuncuoğlu Şerefeddin Training and Research Hospital. Data were collected through face-to-face interviews using a Personal Information Form and the 11-item Subjective Oral Dryness Assessment Form. Salivary pH was assessed using a pH indicator, while objective oral dryness was evaluated using the Modified Schirmer Test. Salivary flow rate was not directly measured.
Results: The mean xerostomia symptom score was 24.05±12.60 (possible score range: 0-110), with thirst being the most frequently reported symptom. No statistically significant difference was observed between pre- and post-haemodialysis objective oral dryness scores. Salivary pH values were within the physiological range. No statistically significant associations were found between xerostomia symptom scores and demographic characteristics, medication use, salivary pH, or clinical oral health indicators. Furthermore, no significant correlation was identified between xerostomia symptom scores and objective oral dryness measurements obtained using the Modified Schirmer Test.
Conclusion: The absence of a significant correlation between xerostomia symptoms and objective oral dryness assessed using the Modified Schirmer Test suggests that subjective and objective indicators of oral dryness may not always correspond. Therefore, integrating the assessment of subjective symptoms with objective findings into routine nursing assessment may facilitate the early identification of individual needs and support the planning of targeted, individualised supportive care for patients undergoing haemodialysis

Anahtar Kelimeler

Etik Beyan

Ethical approval was obtained from the Amasya University Non-Interventional Research Ethics Committee (no: E-30640013-050.04-231088) on 10 December 2024.

Teşekkür

We extend our gratitude to the patients who participated in the study.

Kaynakça

  1. Levin A, Stevens PE, Bilous RW, Coresh J, De Francisco ALM, De Jong PE, et al. Kidney disease: improving global outcomes (KDIGO) CKD work group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3(1):1-150. https://doi.org/10.1038/kisup.2012.73
  2. Mills KT, Xu Y, Zhang W, Bundy JD, Chen CS, Kelly TN, et al. A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010. Kidney Int. 2015;88(5):950-7. https://doi.org/10.1038/ki.2015.230
  3. Thurlow JS, Joshi M, Yan G, Norris KC, Agodoa LY, Yuan CM, et al. Global epidemiology of end-stage kidney disease and disparities in kidney replacement therapy. Am J Nephrol. 2021;52(2):98-107. https://doi.org/10.1159/000514550
  4. Davison SN, Jhangri GS. Impact of pain and symptom burden on the health-related quality of life of hemodialysis patients. J Pain Symptom Manage. 2010;39(3):477-85. https://doi.org/10.1016/j.jpainsymman.2009.08.008
  5. Bossola M, Tazza L. Xerostomia in patients on chronic hemodialysis. Nat Rev Nephrol. 2012;8(3):176-82. https://doi.org/10.1038/nrneph.2011.218
  6. Rodrigues RPCB, Vidigal MTC, Vieira WA, Nascimento GG, Sabino-Silva R, Blumenberg C, et al. Salivary changes in chronic kidney disease and in patients undergoing hemodialysis: a systematic review and meta-analysis. J Nephrol. 2022;35(5):1339-67. https://doi.org/10.1007/s40620-022-01274-4
  7. Bossola M. Xerostomia in patients on chronic hemodialysis: an update. Semin Dial. 2019. https://doi.org/10.1111/sdi.12821
  8. Zemedikun DT, Chandan JS, Raindi D, Rajgor AD, Gokhale KM, Thomas T, et al. Burden of chronic diseases associated with periodontal diseases: a retrospective cohort study using UK primary care data. BMJ Open. 2021;11(12). https://doi.org/10.1136/bmjopen-2020-048296

Ayrıntılar

Birincil Dil

İngilizce

Konular

Nefroloji Hemşireliği, Hemşirelik (Diğer)

Bölüm

Araştırma Makalesi

Yayımlanma Tarihi

30 Eylül 2026

Gönderilme Tarihi

29 Ocak 2026

Kabul Tarihi

23 Eylül 2026

Yayımlandığı Sayı

Yıl 2026 Cilt: 21 Sayı: 3

Kaynak Göster

APA
Yıldız Ilıman, A., & Erten, A. (2026). Assessment of Xerostomia Levels in Patients Undergoing Hemodialysis Treatment/Hemodiyaliz Tedavisi Gören Hastalarda Kserostomi Düzeyinin Değerlendirilmesi. Nefroloji Hemşireliği Dergisi, 21(3), 153-164. https://doi.org/10.47565/ndthdt.2026.133
AMA
1.Yıldız Ilıman A, Erten A. Assessment of Xerostomia Levels in Patients Undergoing Hemodialysis Treatment/Hemodiyaliz Tedavisi Gören Hastalarda Kserostomi Düzeyinin Değerlendirilmesi. NefroHemDergi. 2026;21(3):153-164. doi:10.47565/ndthdt.2026.133
Chicago
Yıldız Ilıman, Alev, ve Aleyna Erten. 2026. “Assessment of Xerostomia Levels in Patients Undergoing Hemodialysis Treatment/Hemodiyaliz Tedavisi Gören Hastalarda Kserostomi Düzeyinin Değerlendirilmesi”. Nefroloji Hemşireliği Dergisi 21 (3): 153-64. https://doi.org/10.47565/ndthdt.2026.133.
EndNote
Yıldız Ilıman A, Erten A (01 Eylül 2026) Assessment of Xerostomia Levels in Patients Undergoing Hemodialysis Treatment/Hemodiyaliz Tedavisi Gören Hastalarda Kserostomi Düzeyinin Değerlendirilmesi. Nefroloji Hemşireliği Dergisi 21 3 153–164.
IEEE
[1]A. Yıldız Ilıman ve A. Erten, “Assessment of Xerostomia Levels in Patients Undergoing Hemodialysis Treatment/Hemodiyaliz Tedavisi Gören Hastalarda Kserostomi Düzeyinin Değerlendirilmesi”, NefroHemDergi, c. 21, sy 3, ss. 153–164, Eyl. 2026, doi: 10.47565/ndthdt.2026.133.
ISNAD
Yıldız Ilıman, Alev - Erten, Aleyna. “Assessment of Xerostomia Levels in Patients Undergoing Hemodialysis Treatment/Hemodiyaliz Tedavisi Gören Hastalarda Kserostomi Düzeyinin Değerlendirilmesi”. Nefroloji Hemşireliği Dergisi 21/3 (01 Eylül 2026): 153-164. https://doi.org/10.47565/ndthdt.2026.133.
JAMA
1.Yıldız Ilıman A, Erten A. Assessment of Xerostomia Levels in Patients Undergoing Hemodialysis Treatment/Hemodiyaliz Tedavisi Gören Hastalarda Kserostomi Düzeyinin Değerlendirilmesi. NefroHemDergi. 2026;21:153–164.
MLA
Yıldız Ilıman, Alev, ve Aleyna Erten. “Assessment of Xerostomia Levels in Patients Undergoing Hemodialysis Treatment/Hemodiyaliz Tedavisi Gören Hastalarda Kserostomi Düzeyinin Değerlendirilmesi”. Nefroloji Hemşireliği Dergisi, c. 21, sy 3, Eylül 2026, ss. 153-64, doi:10.47565/ndthdt.2026.133.
Vancouver
1.Alev Yıldız Ilıman, Aleyna Erten. Assessment of Xerostomia Levels in Patients Undergoing Hemodialysis Treatment/Hemodiyaliz Tedavisi Gören Hastalarda Kserostomi Düzeyinin Değerlendirilmesi. NefroHemDergi. 01 Eylül 2026;21(3):153-64. doi:10.47565/ndthdt.2026.133

Nefroloji Hemşireliği Dergisi/ Journal of Nephrology Nursing Creative Commons Lisansı Creative Commons Atıf-GayriTicari-Türetilemez 4.0 Uluslararası Lisansı ile lisanslanmıştır.